Both medications influence hormonal pathways that regulate insulin sensitivity, blood-sugar balance, appetite, and metabolic rate which can contribute to improved overall metabolic health beyond just fat loss
Hydrocortisone [ep Monograph] 327
LH: Methodology, Supervision, Writing review & editing
Clinical studies have shown that GLP-1 medications can effectively promote weight loss in patients who do not have diabetes
Results showed that a greater proportion of subjects in the placebo group experienced MACE over the follow-up period (701 of 8,801 patients, or 8.0%) than in the semaglutide group (569 of 8,803 patients, or 6.5%)
The following peptides are promising for combination with Semaglutide: Insulin-sensitizing peptides (e.g., analogs of GLP-1, GIP, or related peptides) may complement semaglutides glucose-lowering effects